Stocks to watch on Monday after Q4 results: Infosys, Jio Financial Services, Tata Elxsi, HDFC AMC, and more | Stock Market News

Stocks to watch on Monday after Q4 results: Infosys, Jio Financial Services, Tata Elxsi, HDFC AMC, and more | Stock Market News

Source: Live Mint Here’s a quick look at stocks likely to be in focus in Monday’s trade after declaring their respective March quarter results (Q4FY25). Several prominent companies announced their March quarter (Q4FY25) earnings ahead of the trading session on Monday, setting the stage for stock-specific action in the market. From tech giants like Infosys…

Read More
Stocks to buy under  ₹100: Mehul Kothari of Anand Rathi recommends three shares to buy or sell | Stock Market News

Stocks to buy under ₹100: Mehul Kothari of Anand Rathi recommends three shares to buy or sell | Stock Market News

Source: Live Mint Stocks to buy under ₹100: Following positive sentiments after US President Donald Trump declared a 90-day pause in the US tariffs recently imposed on its trade partners, the Indian stock market skyrocketed on Friday. The Nifty 50 index opened upside at 22,695 and closed at 22,828, recording an intraday rise of 429…

Read More
Aurionpro Solutions shares surge over 15% on acquisition of Fintra Software | Stock Market News

Aurionpro Solutions shares surge over 15% on acquisition of Fintra Software | Stock Market News

Source: Live Mint Shares of Aurionpro Solutions soared over 15 percent in intra-day trade on Friday, April 11, after the company announced the acquisition of Hyderabad-based Fintra Software Private Limited in a strategic move to strengthen its next-generation trade finance solutions for global banks. The deal involves a complete 100 percent acquisition of Fintra, including…

Read More
Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE | Stock Market News

Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE | Stock Market News

Source: Live Mint Biocon’s share price surged 5.5 percent in intra-day trade on Friday, April 11, after the company’s subsidiary, Biocon Biologics, received approval from the US Food and Drug Administration (USFDA) for JOBEVNE, a biosimilar version of Bevacizumab for intravenous use. The development marks a key regulatory milestone for the company and reinforces investor…

Read More
Bank of Maharashtra rebounds 20% from 52-week low after strong Q4 business update | Stock Market News

Bank of Maharashtra rebounds 20% from 52-week low after strong Q4 business update | Stock Market News

Source: Live Mint Shares of state-owned Bank of Maharashtra jumped 20 percent from their 52-week low on Tuesday, April 8, after the lender released a strong business update for the March 2025 quarter (Q4 FY25). The sharp rebound in the stock price came as the bank reported solid year-on-year growth across key business indicators, signaling…

Read More